The current treatment paradigm for muscle-invasive bladder cancer (MIBC) consists of
cisplatin-based neoadjuvant chemotherapy followed by local definitive therapy, or local definitive …

Introduction Immune checkpoint inhibitors (ICIs) are increasingly used to treat cancers. Kidney
immune-related adverse events (IRAEs) are now well recognized, with the incidence of …

Background Immune checkpoint inhibitor-associated acute kidney injury (ICPi-AKI) has emerged
as an important toxicity among patients with cancer. Methods We collected data on 429 …

Immune checkpoint inhibitors (ICIs), immunomodulatory antibodies that are used to enhance
the immune system, have substantially improved the prognosis of patients with advanced …

Background Immune checkpoint inhibitors (ICPi) are a novel and promising anti-cancer therapy.
There are limited data on the incidence, risk factors and outcomes of acute kidney injury …

Background Despite increasing recognition of the importance of immune checkpoint
inhibitor–associated AKI, data on this complication of immunotherapy are sparse. Methods We …

Some β-blockers are efficiently removed from the circulation by hemodialysis (“high
dialyzability”) whereas others are not (“low dialyzability”). This characteristic may influence the …

Background The risk of hospital readmission in acute kidney injury survivors is not well
understood. We estimated the proportion of acute kidney injury patients who were rehospitalized …

Objective: Among critically ill patients with acute kidney injury, the impact of renal replacement
therapy modality on long-term kidney function is unknown. Compared with conventional …

Cardiac amyloidosis is an under-recognized and potentially fatal cause of heart failure and
other cardiovascular manifestations. It is caused by deposition of misfolded precursor …